Below Expected Outlook Pressured Boston Scientific (BSX) in Q1
Renaissance Investment Management, an investment management company, released its Q1 2026 “Large Cap Growth Strategy.” A copy of the letter …
معلومات السوق الآنية عبر فئات الأصول
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
| المطلع | المنصب | التاريخ | النوع | القيمة |
|---|---|---|---|---|
| Monson Jonathan | EVP and … | Jul 01 '26 | Option Exercise | 0,0 |
| Pegus Cheryl | Director | May 20 '26 | Buy | 99987,0 |
| LUDWIG EDWARD J | Director | May 20 '26 | Buy | 202914,0 |
| Habiger David C | Director | May 20 '26 | Buy | 125819,0 |
| Habiger David C | Director | May 19 '26 | Buy | 125279,0 |
| O'Connor Padraig Andrew | EVP, Global … | May 02 '26 | Option Exercise | 0,0 |
| Butcher Arthur C | EVP& Grp … | May 02 '26 | Option Exercise | 0,0 |
| Woodworth Emily | SVP, Global … | Mar 01 '26 | Option Exercise | 0,0 |
| O'Connor Padraig Andrew | EVP, Global … | Feb 16 '26 | Option Exercise | 0,0 |
| O'Connor Padraig Andrew | EVP, Global … | Feb 14 '26 | Option Exercise | 0,0 |
المصدر: FinViz — قد تكون البيانات متأخرة
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر BSX والمشاعر والاتجاه
Renaissance Investment Management, an investment management company, released its Q1 2026 “Large Cap Growth Strategy.” A copy of the letter …
Boston Scientific Corporation (NYSE:BSX) is among the 10 Most Oversold S&P 500 Stocks So Far in 2026. On May 29, …
Investors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today, May 27, 2026.
The medical device maker flags a drop in stand-alone procedures for its Watchman heart implant, hitting its near-term growth forecast.
تحليل متعدد المزودين بالذكاء الاصطناعي